Mochimganine
Mochimganine has been studied in 1 paper since 2022: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Apr 14, 2022: “Tschimganine has different targets for chronological lifespan extension and growth inhibition in fission yeast”.
See all 1 papers on mochimganine
At a glance
The findings reach worms or flies, none yet in people. 1 lab in 1 country.
Worms or flies: a single group. Cells, mice and humans: nothing yet.
- 1 lab in 1 country
- Funder: Japan Society for the Promotion of Science
- Cells1
What did studies of mochimganine find?
1Studies of mochimganine measured one outcome, lifespan.
Lifespan
upin fission yeast cells1
1 study
Lifespan
upin fission yeast cells1
Mochimganine extends lifespan in fission yeast cells.
“We synthesized a Tschimganine analog, Mochimganine, which extends the lifespan similar to Tschimganine but exhibits a significantly weaker growth inhibition effect.”
Cells
Bioscience, biotechnology, and biochemistry
Latest
Bioscience, Biotechnology, and Biochemistry
Tschimganine has different targets for chronological lifespan extension and growth inhibition in fission yeast
Experiments in yeastInterventions